See LEGEND for key to shading and symbols.
Subject Area - PHAR Term - Term 3 2021
PHAR2011 | PHAR3101 | PHAR9104 | PHAR9118 | PHAR9121 |
Data is correct as at Tue 28 Sep 20:30:55 AEST 2021
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHAR2011 | Introductory Pharmacology and | ||||||
CRS | CR01 | 2518 | Open | 0/10 | 0% | (Course Enrolment, UGRD) | |
LAB | T10A | 5027 | Enr | Open | 67/68 | 99% | Tue 10-13 (w1,3,5,7,9, Online) |
LAB | T10B | 5028 | Enr | Open | 66/68 | 97% | Tue 10-13 (w1,2,4,8,10, Online) |
LAB | T10C | 5029 | Enr | Open* | 1/2 | 50% | Tue 10-13 (w1,3,5,7,9, Online) |
LAB | T10D | 5030 | Enr | Open* | 0/2 | 0% | Tue 10-13 (w1-2,4,8,10, Online) |
LAB | T14A | 5031 | Enr | Open | 67/68 | 99% | Tue 14-17 (w1,3,5,7,9, Online) |
LAB | T14B | 5032 | Enr | Open | 67/68 | 99% | Tue 14-17 (w1,2,4,8,10, Online) |
LAB | T14C | 5033 | Enr | Open* | 0/2 | 0% | Tue 14-17 (w1,3,5,7,9, Online) |
LAB | T14D | 5034 | Enr | Full* | 2/2 | 100% | Tue 14-17 (w1-2,4,8,10, Online) |
LEC | A | 5016 | Rel | Open | 270/280 | 96% | Mon 11# (w1-3,5,7-10, Online); Wed 17# (w1-5,7-10, Online) |
TUT | F11A | 5017 | Rel | Full | 34/34 | 100% | Fri 11 (w1-5,7-10, Online) |
TUT | F11B | 5018 | Rel | Open | 33/35 | 94% | Fri 11 (w1-5,7-10, Online) |
TUT | F11C | 5019 | Rel | Open* | 4/5 | 80% | Fri 11 (w1-5,7-10, Online) |
TUT | F12A | 5020 | Rel | Open | 31/33 | 94% | Fri 12 (w1-5,7-10, Online) |
TUT | F12B | 5021 | Rel | Full | 34/34 | 100% | Fri 12 (w1-5,7-10, Online) |
TUT | F12C | 5022 | Rel | Tent* | 0/2 | 0% | Fri 12 (w1-5,7-10, Online) |
TUT | H13A | 5023 | Rel | Open | 33/34 | 97% | Thu 13 (w1-5,7-10, Online) |
TUT | H13B | 5024 | Rel | Open | 34/35 | 97% | Thu 13 (w1-5,7-10, Online) |
TUT | H14A | 5025 | Rel | Full | 34/34 | 100% | Thu 14 (w1-5,7-10, Online) |
TUT | H14B | 5026 | Rel | Open | 33/34 | 97% | Thu 14 (w1-5,7-10, Online) |
PHAR3101 | Drug Discovery, Design & Devel | ||||||
CRS | CR01 | 2655 | Open | 0/7 | 0% | (Course Enrolment, UGRD) | |
LAB | W14A | 5778 | Rel | Open | 66/75 | 88% | Wed 14-17 (w1-5,7-10, Online) |
LAB | W14B | 5779 | Rel | Open* | 2/5 | 40% | Wed 14-17 (w1-5,7-10, Online) |
LE1 | WEB1 | 5780 | Auto | Open | 68/76 | 89% | |
LE2 | LE21 | 5776 | Rel | Open | 68/76 | 89% | Thu 13# (w1-4,7-10, Online) |
OTH | OTH1 | 5777 | Rel | Open | 68/76 | 89% | Thu 13 (w5, Online) |
TUT | F09A | 5773 | Enr | Open | 32/35 | 91% | Fri 09 (w1-5,7-10, Online) |
TUT | F13A | 5774 | Enr | Open | 34/35 | 97% | Fri 13 (w1-5,7-10, Online) |
TUT | F13B | 5775 | Enr | Open* | 2/5 | 40% | Fri 13 (w1-5,7-10, Online) |
PHAR9104 | Regulatory Affairs | ||||||
CRS | CR01 | 1267 | Open | 0/9 | 0% | (Course Enrolment, PGRD) | |
DST | DST1 | 3550 | Enr | Open | 21/30 | 70% | |
PHAR9118 | Therapeutics | ||||||
CRS | CR01 | 1171 | Open | 0/13 | 0% | (Course Enrolment, PGRD) | |
DST | DST1 | 3551 | Enr | Open | 17/30 | 57% | |
PHAR9121 | Pharmacovigilance | ||||||
CRS | CR01 | 1103 | Open | 0/52 | 0% | (Course Enrolment, PGRD) | |
DST | DST1 | 3565 | Enr | Open | 8/60 | 13% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |